The reaction simplifies the production of pharmaceutically important molecules called lactones and other complex compounds.
Scientists say you can now use Osimertinib -a cancer drug- just once a week instead of daily and still be safe from tumour regrowths.
Study identifies the role of DLX1 gene in prostate cancer demonstrating how its elimination leads to reduced carcinogenesis in mice models
Research finds that cancer cells of different sizes and stiffness are more invasive than a group of uniform cells.
Researchers have found how cancer cells hoodwink the biological clock controls and use them to promote tumour growth.
Researchers have identified two groups of genes that switch activity and help cancer cells evade therapy and spread aggressively.
Researchers have identified a set of proteins that can distinguish between ovarian cancer and benign tumors.
In the first-ever study from India, researchers at the National Centre for Biological Sciences (NCBS), Bengaluru and the Tata Memorial Hospital, Mumbai, have analysed how prevalent the Merkel Cell Polyomavirus (MCV) is in India.
Among the various types of cancer, Urothelial Bladder Cancer (UBC) is responsible for around 2 lakh deaths per year around the world. This cancer affects the inner lining of the bladder and is the most common form of bladder cancer. It usually affects aged individuals, with blood in urine and painful urination as the first sign of its manifestation. Conventional methods of treatment involve surgical removal of cancerous tissue in the bladder and chemotherapy.
About 6,000 years ago, an unfortunate dog suffered from a relatively rare form of cancer. Since then, unlike any other cancer, its cancer cells were swiftly transmitted from one dog to another. Today, this age-old ailment has a name—Canine Transmissible Venereal Tumour or CTVT. In a recent study, they traced the history of CTVT to Asia, and in the process, helped understand the evolution of cancer in the long term.
A team of researchers from Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, have reported a new compound that has shown promising potential to fight against cervical cancer.